176 related articles for article (PubMed ID: 18094508)
1. Osteonecrosis and osteonecrosis of the jaw (ONJ).
Kim HK
J Musculoskelet Neuronal Interact; 2007; 7(4):348-9. PubMed ID: 18094508
[No Abstract] [Full Text] [Related]
2. Introduction to osteonecrosis of the femoral head (OFH) and osteonecrosis of the jaw (ONJ).
Kim HK
J Musculoskelet Neuronal Interact; 2007; 7(4):350-3. PubMed ID: 18094509
[No Abstract] [Full Text] [Related]
3. Distinguishing features of the oral cavity and its predisposition to osteonecrosis.
McCauley LK; Li X
J Musculoskelet Neuronal Interact; 2007; 7(4):356-7. PubMed ID: 18094511
[No Abstract] [Full Text] [Related]
4. Animal models of osteonecrosis of the jaw.
Allen MR
J Musculoskelet Neuronal Interact; 2007; 7(4):358-60. PubMed ID: 18094512
[No Abstract] [Full Text] [Related]
5. Potential pathophysiological mechanisms in osteonecrosis of the jaw.
Landesberg R; Woo V; Cremers S; Cozin M; Marolt D; Vunjak-Novakovic G; Kousteni S; Raghavan S
Ann N Y Acad Sci; 2011 Feb; 1218():62-79. PubMed ID: 21291478
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O; Kouri M; Papadopoulou E; Vardas E; Galiti D; Epstein JB; Elad S; Campisi G; Tsoukalas N; Bektas-Kayhan K; Tan W; Body JJ; Migliorati C; Lalla RV;
Support Care Cancer; 2019 Feb; 27(2):383-394. PubMed ID: 30353228
[TBL] [Abstract][Full Text] [Related]
7. [Bisphosphonates and osteonecrosis of the jaw].
Saussez S; Filleul O; Loeb I
Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means for future studies.
Allen MR; Pandya B; Ruggiero SL
J Oral Maxillofac Surg; 2010 Nov; 68(11):2730-4. PubMed ID: 20869151
[TBL] [Abstract][Full Text] [Related]
9. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference.
Bilezikian JP; Grbic JT
Ann N Y Acad Sci; 2011 Feb; 1218():1-2. PubMed ID: 21291476
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw in a patient treated with ibandronate.
Vomvas D; Vassiliou V; Papavasileiou D; Kalogeropoulou C; Nicolatou-Galitis O; Kardamakis D
J BUON; 2008; 13(3):441-2. PubMed ID: 18979566
[No Abstract] [Full Text] [Related]
12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
Lewis DM
J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
[No Abstract] [Full Text] [Related]
14. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the jaw associated with bisphosphonate therapy.
Wirth SM; Lawson AP; Sutphin SD; Adams VR
Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
[No Abstract] [Full Text] [Related]
16. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis.
Tubiana-Hulin M; Spielmann M; Roux C; Campone M; Zelek L; Gligorov J; Samson J; Lesclous P; Laredo JD; Namer M
Crit Rev Oncol Hematol; 2009 Jul; 71(1):12-21. PubMed ID: 19070505
[TBL] [Abstract][Full Text] [Related]
17. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
Tsai KY; Huang CS; Huang GM; Yu CT
J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569
[No Abstract] [Full Text] [Related]
18. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonate-associated osteonecrosis of the jaw].
Abu-Id MH; Açil Y; Gottschalk J; Kreusch T
Mund Kiefer Gesichtschir; 2006 Mar; 10(2):73-81. PubMed ID: 16456688
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
